Phase II evaluation of oral medroxyprogesterone acetate in advanced breast cancer: a Northern California Oncology Group Study

Cancer Treat Rep. 1987 Oct;71(10):969-70.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Drug Evaluation
  • Female
  • Humans
  • Medroxyprogesterone / adverse effects
  • Medroxyprogesterone / analogs & derivatives*
  • Medroxyprogesterone / therapeutic use
  • Medroxyprogesterone Acetate
  • Menopause
  • Middle Aged

Substances

  • Medroxyprogesterone Acetate
  • Medroxyprogesterone